Vericel Corp. (NASDAQ:VCEL)’s share price traded down 3.2% during trading on Thursday . The stock traded as low as $2.45 and last traded at $2.45, with a volume of 64,194 shares changing hands. The stock had previously closed at $2.53.

The firm’s market capitalization is $51.66 million. The firm’s 50-day moving average is $2.21 and its 200-day moving average is $2.79.

Vericel Corp. (NASDAQ:VCEL) last posted its quarterly earnings results on Monday, August 8th. The company reported ($0.21) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.16) by $0.05. The business had revenue of $12.80 million for the quarter, compared to analysts’ expectations of $15.05 million. Equities research analysts expect that Vericel Corp. will post ($0.91) earnings per share for the current year.

Vericel Corporation, formerly Aastrom Biosciences, Inc, is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.